Augustine Therapeutics Denmark ApS
CVR 45553493 · Private limited company (ApS) · Active · Medium risk
Augustine Therapeutics Denmark ApS is a Private limited company (ApS), founded on , based in Frederiksberg. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 1.4% over the next 12 months, which is 1.0 times the average for Danish companies. 1 annual report has been published, of which 1 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 812k and a net result of DKK 65k. CEO: Gerhard Koenig, Virginie Cartage.
Bankruptcy risk for Augustine Therapeutics Denmark ApS
1.0 × the average (1.41%) · higher risk than 75% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 45553493
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (1 years)
- Address
- Nordre Fasanvej 215
2000 Frederiksberg - Municipality
- Frederiksberg
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 3,000
- Auditor
- EY Godkendt Revisionspartnerselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 1 of 1 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 30.6% |
| Current ratio | 495% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 111 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 |
|---|---|
| Gross profit | DKK 109k |
| Net profit | DKK 65k |
| Equity | DKK 812k |
| Total assets | DKK 2.6m |
| Cash | DKK 724k |
| Short-term debt | DKK 526k |
| Tax owed | DKK 18k |
| Avg. employees | 1 |
Latest annual report: Reporting class B · auditor's statement: Den uafhængige revisors erklæring · EY Godkendt Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 10 Apr 2025 – 31 Dec 2025 | 188 | Late |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Gerhard Koenig | Current | |
| CEO | Virginie Cartage | Current | |
| Owner (100%) | Augustine Therapeutics NV | Current | |
| Auditor | EY Godkendt Revisionspartnerselskab | Current | |
| Founder | Augustine Therapeutics NV | Current |
Address history (0 moves)
| Nordre Fasanvej 215, 2000 Frederiksberg |
Other companies at the same address
- Nordetect ApS Bankrupt
- ACESION PHARMA ApS Active
- AdaptVac ApS Active
- Adcendo ApS Active
- Akylox Therapeutics ApS Active
- Antraka ApS Opløst
- Autocert ApS Active
- Avancert ApS Active
- B4C ApS Active
- BOOST Pharma ApS Active
- Baekmark IP Consult ApS Active
- Betula Capital ApS Active
- BioPhenyx ApS Active
- Biobridge Partners ApS Active
- Biotinia ApS Active
- CMCAssist ApS Active
- CMCGreenhouse ApS Active
- CMCHoldings ApS Active
- CaMaRa ApS Active
- Catalyst Vaccination A/S Active
- Chris Cording Jønsson Holding ApS Active
- DARERL ApS Active
- DFY ApS Active
- DeltaBot ApS Active
- Details ApS Active
Similar companies in Frederiksberg
- Koblano Therapeutics ApS Frederiksberg
- Eygo Bio ApS Frederiksberg
- LumenAR ApS Frederiksberg
- IDTA ApS Frederiksberg
- Valicentra ApS Frederiksberg
- Silvics ApS Frederiksberg
- InLife Research ApS Frederiksberg
- NordicRWE Denmark ApS Frederiksberg C
- CaMaRa ApS Frederiksberg
- Hvidberg Compliance Management Aps Frederiksberg
- Vibraint ApS Frederiksberg
- OligoMaker Cph ApS Frederiksberg
Questions and answers about Augustine Therapeutics Denmark ApS
Has Augustine Therapeutics Denmark ApS gone bankrupt?
No, Augustine Therapeutics Denmark ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Augustine Therapeutics Denmark ApS?
Our model estimates a bankruptcy risk of 1.4% over the next 12 months (medium risk), which is 1.0 times the average for Danish companies.
Who is the CEO of Augustine Therapeutics Denmark ApS?
Gerhard Koenig, Virginie Cartage are the CEOs of Augustine Therapeutics Denmark ApS.
Who is the auditor of Augustine Therapeutics Denmark ApS?
Augustine Therapeutics Denmark ApS most recently used EY Godkendt Revisionspartnerselskab.
When was Augustine Therapeutics Denmark ApS founded?
Augustine Therapeutics Denmark ApS was founded on 10 April 2025.
What is the equity of Augustine Therapeutics Denmark ApS?
Equity was DKK 812k according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.